Adrine Kung is currently the Vice President of Clinical Operations at TORL Biotherapeutics. Prior to this, they held various leadership roles in clinical operations and research collaborations at companies such as TRIO-US, Inc., 1200 Pharma, City of Hope, Mayo Clinic, and Minneapolis Medical Research Foundation. Adrine has also worked as an Associate at Health Systems Innovation Network, LLC, a Fellow at University of Minnesota - Carlson School of Management, and as a Senior Clinical Research Coordinator at Park Nicollet Health Services. Adrine holds an MBA in Strategy and Medical Industry Leadership Institute Specialization from University of Minnesota - Carlson School of Management and a Bachelor of Science in Biochemistry from the University of Minnesota.
April, 2021 - present